midi health microdosing glp 1 GLP-1 THE GLP-1 MICRODOSING PROGRAM

While early data suggests limited risks for liver function and other markers of toxicity, other studies suggest a risk may be present after all

These medications are relatively new at weight loss concentrations, and we have only as much data as the clinical trials have offered

Taking tirzepatide a day early is generally safe if it helps you stay on schedule during travel

Strength and longevity: With every pound lost, Angelia became more aware of the importance of maintaining strength as she aged

Absolute contraindications to GLP-1 receptor agonists include: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 Previous serious hypersensitivity reaction to the specific GLP-1 drug Pregnancy and breastfeeding (for medications approved for weight management: Wegovy, Saxenda, and Zepbound) Patients should maintain age-appropriate cancer screening regardless of GLP-1 use